{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:11:36Z","timestamp":1779333096360,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Provincial Natural Science Foundation General Project","award":["No.2019A1515010690"],"award-info":[{"award-number":["No.2019A1515010690"]}]},{"name":"Guangzhou Municipal Science and Technology Plan Project","award":["No.202002030014"],"award-info":[{"award-number":["No.202002030014"]}]},{"name":"Guangzhou Municipal Science and Technology Plan Project","award":["No.202102010071"],"award-info":[{"award-number":["No.202102010071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12010-026-05650-9","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:15:49Z","timestamp":1774080949000},"page":"4465-4481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and Functional Role of HELLS in Prostate Cancer: Implications for Tumor Progression and Immune Microenvironment"],"prefix":"10.1007","volume":"198","author":[{"given":"Canwei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1984-4600","authenticated-orcid":false,"given":"Zhuangwen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"5650_CR1","doi-asserted-by":"crossref","unstructured":"LIANG, Y., & ZHANG, X. MA C, et al. m(6)A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Cancer. Cancers (Basel), 2022,14(16).","DOI":"10.3390\/cancers14164035"},{"issue":"1","key":"5650_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13578-023-00985-w","volume":"13","author":"YH CHEN","year":"2023","unstructured":"CHEN, Y. H., CHEN, H., LIN T T, et al. (2023). ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes. Cell Biosci, 13(1), 38.","journal-title":"Cell Biosci"},{"issue":"3","key":"5650_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/jpet.119.261040","volume":"371","author":"J CHENG","year":"2019","unstructured":"CHENG, J., MOORE, S., GOMEZ-GALENO J, et al. (2019). A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer. Journal Of Pharmacology And Experimental Therapeutics, 371(3), 703\u2013712.","journal-title":"Journal Of Pharmacology And Experimental Therapeutics"},{"issue":"1","key":"5650_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","volume":"10","author":"JA SIDDIQUI","year":"2022","unstructured":"SIDDIQUI, J. A., & SESHACHARYULU, P. (2022). GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation. Bone Res, 10(1), 6.","journal-title":"Bone Res"},{"issue":"1","key":"5650_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/10717544.2022.2050845","volume":"29","author":"X ZHANG","year":"2022","unstructured":"ZHANG, X., LIU, Q., ZHANG, T., et al. (2022). Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment. Drug Deliv, 29(1), 889\u2013905.","journal-title":"Drug Deliv"},{"issue":"6","key":"5650_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0881","volume":"86","author":"J Li","year":"2025","unstructured":"Li, J., & Wang, W. (2025). The Predictive Value of Serum miR-141-3p, Fibrinogen, and Prostate-Specific Antigen Levels for Bone Metastasis in Prostate Cancer. British Journal Of Hospital Medicine (London, England : 2005), 86(6), 1\u201312.","journal-title":"British Journal Of Hospital Medicine (London, England : 2005)"},{"key":"5650_CR7","doi-asserted-by":"crossref","unstructured":"ZHAO, W., & ZHU, X. (2022). JIN Q, et al. The lncRNA NEAT1\/miRNA\u2013766\u20135p\/E2F3 Regulatory Axis Promotes Prostate Cancer Progression. J Oncol, 2022: 1866972.","DOI":"10.1155\/2022\/1866972"},{"key":"5650_CR8","doi-asserted-by":"crossref","unstructured":"HAN, Y., & WEN, X. (2022). CHEN D, et al. Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer. J Oncol, 2022: 6358707.","DOI":"10.1155\/2022\/6358707"},{"key":"5650_CR9","doi-asserted-by":"publisher","first-page":"e16451","DOI":"10.7717\/peerj.16451","volume":"11","author":"W TIE","year":"2023","unstructured":"TIE, W., & GE, F. (2023). Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression. PeerJ, 11, e16451.","journal-title":"PeerJ"},{"issue":"2","key":"5650_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/CBM-230073","volume":"38","author":"Y FANG","year":"2023","unstructured":"FANG, Y., & TANG, W. (2023). Immunological function and prognostic value of lymphoid-specific helicase in liver hepatocellular carcinoma. Cancer Biomark, 38(2), 225\u2013239.","journal-title":"Cancer Biomark"},{"key":"5650_CR11","doi-asserted-by":"crossref","unstructured":"PEIXOTO, E., KHAN, A., LEWIS Z A (2022). The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. International Journal Of Molecular Sciences, 23(16).","DOI":"10.3390\/ijms23169313"},{"key":"5650_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12935-020-1104-7","volume":"20","author":"Y She","year":"2020","unstructured":"She, Y., Kong, X., Ge, Y., et al. (2020). Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. Cancer Cell International, 20, 22.","journal-title":"Cancer Cell International"},{"issue":"4","key":"5650_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ol.2020.11958","volume":"20","author":"P HE","year":"2020","unstructured":"HE, P., XIONG, G., GUO, W., et al. (2020). Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/beta-catenin signaling pathway. Oncol Lett, 20(4), 97.","journal-title":"Oncol Lett"},{"issue":"1","key":"5650_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41467-023-35880-y","volume":"14","author":"T TSUJINO","year":"2023","unstructured":"TSUJINO, T., TAKAI, T., HINOHARA, K., et al. (2023). CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications, 14(1), 252.","journal-title":"Nature Communications"},{"key":"5650_CR15","doi-asserted-by":"crossref","unstructured":"ZHANG, G., DONG Z, PRAGER B C (2019). Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. JCI Insight, 4(7).","DOI":"10.1172\/jci.insight.126140"},{"issue":"4","key":"5650_CR16","doi-asserted-by":"publisher","first-page":"8311","DOI":"10.1080\/21655979.2022.2048945","volume":"13","author":"C HE","year":"2022","unstructured":"HE, C. (2022). Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR\u20131305\/helicase, lymphoid specific (HELLS) axis. Bioengineered, 13(4), 8311\u20138322.","journal-title":"Bioengineered"},{"issue":"2","key":"5650_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41416-021-01543-2","volume":"126","author":"X CHEN","year":"2022","unstructured":"CHEN, X., LI, Y., RUBIO, K., et al. (2022). Lymphoid-specific helicase in epigenetics, DNA repair and cancer. British Journal Of Cancer, 126(2), 165\u2013173.","journal-title":"British Journal Of Cancer"},{"issue":"1","key":"5650_CR18","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1038\/s41467-023-41317-3","volume":"14","author":"C COUSU","year":"2023","unstructured":"COUSU, C., MULOT, E., De, S. M. E. T. A., et al. (2023). Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells. Nature Communications, 14(1), 5695.","journal-title":"Nature Communications"},{"issue":"25","key":"5650_CR19","doi-asserted-by":"publisher","first-page":"37846","DOI":"10.18632\/oncotarget.9344","volume":"7","author":"R HOOGLAND A M, BOTTCHER","year":"2016","unstructured":"HOOGLAND A M, BOTTCHER, R., VERHOEF, E., et al. (2016). Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer. Oncotarget, 7(25), 37846\u201337856.","journal-title":"Oncotarget"},{"issue":"4","key":"5650_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/emboj.2011.451","volume":"31","author":"EYSSB von MAASKOLA","year":"2012","unstructured":"von MAASKOLA, E. Y. S. S. B. (2012). The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. Embo Journal, 31(4), 972\u2013985.","journal-title":"Embo Journal"},{"key":"5650_CR21","doi-asserted-by":"publisher","first-page":"870726","DOI":"10.3389\/fimmu.2022.870726","volume":"13","author":"X Liang","year":"2022","unstructured":"Liang, X., Li, L., & Fan, Y. (2022). Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis. Frontiers In Immunology, 13, 870726.","journal-title":"Frontiers In Immunology"},{"key":"5650_CR22","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1016\/j.csbj.2023.09.020","volume":"21","author":"X Du","year":"2023","unstructured":"Du, X., ZHANG, X., QI, Z., et al. (2023). HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype. Comput Struct Biotechnol J, 21, 5174\u20135185.","journal-title":"Comput Struct Biotechnol J"},{"key":"5650_CR23","doi-asserted-by":"publisher","first-page":"115976","DOI":"10.1016\/j.biopha.2023.115976","volume":"170","author":"Q SHANG","year":"2023","unstructured":"SHANG, Q., & YU, X. (2023). Polysaccharides regulate Th1\/Th2 balance: A new strategy for tumor immunotherapy. Biomedicine & Pharmacotherapy, 170, 115976.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"5650_CR24","first-page":"521","volume":"103","author":"R Novysedlak","year":"2025","unstructured":"Novysedlak, R., Guney, M., Al Khouri, M., et al. (2025). The Immune Microenvironment in Prostate Cancer: A Comprehensive Review. Oncology (Williston Park, N.Y.), 103(6), 521\u2013545.","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"1","key":"5650_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","volume":"380","author":"SL Shiao","year":"2016","unstructured":"Shiao, S. L., Chu, G. C., & Chung, L. W. (2016). Regulation of prostate cancer progression by the tumor microenvironment. Cancer Letters, 380(1), 340\u2013348.","journal-title":"Cancer Letters"},{"issue":"1","key":"5650_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cam4.3627","volume":"10","author":"X HOU","year":"2021","unstructured":"HOU, X., & WANG, Y. A. N. G. L. (2021). HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3. Cancer Medicine, 10(1), 350\u2013364.","journal-title":"Cancer Medicine"},{"issue":"5","key":"5650_CR27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/hep.30414","volume":"69","author":"CT Law","year":"2019","unstructured":"Law, C. T., Wei, L., Tsang, F. H., Chan, C. Y., Xu, I. M., Lai, R. K., Ho, D. W., Lee, J. M., Wong, C. C., Ng, I. O., & Wong, C. M. (2019). HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma. Hepatology, 69(5), 2013\u20132030.","journal-title":"Hepatology"},{"key":"5650_CR28","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1016\/j.csbj.2023.09.020","volume":"21","author":"X Du","year":"2023","unstructured":"Du, X., Zhang, X., Qi, Z., Zeng, Z., Xu, Y., Yu, Z., Cao, X., & Xia, J. (2023). HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype. Comput Struct Biotechnol J, 21, 5174\u20135185.","journal-title":"Comput Struct Biotechnol J"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05650-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:36:07Z","timestamp":1779330967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05650-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5650"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05650-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"24 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Our study did not require an ethical board approval because it did not contain human or animal trials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}